These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28582649)

  • 21. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARγ and SUR agonists.
    El-Zahabi MA; Elbendary ER; Bamanie FH; Radwan MF; Ghareib SA; Eissa IH
    Bioorg Chem; 2019 Oct; 91():103115. PubMed ID: 31310882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats.
    Chaudhry J; Ghosh NN; Roy K; Chandra R
    Life Sci; 2007 Feb; 80(12):1135-42. PubMed ID: 17234217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and in-vivo hypoglycemic evaluation of novel non - TZD'S in a type - 2 diabetic model.
    Jadhav R; Gupta-Rajoria R; Pal T; Subramanian RC
    Med Chem; 2013 Feb; 9(1):104-11. PubMed ID: 22762162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPARγ and SUR agonists.
    Ibrahim MK; Eissa IH; Alesawy MS; Metwaly AM; Radwan MM; ElSohly MA
    Bioorg Med Chem; 2017 Sep; 25(17):4723-4744. PubMed ID: 28720328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, hypoglycaemic, hypolipidemic and PPARγ agonist activities of 5-(2-Alkyl/aryl-6-Arylimidazo[2,1-b][1,3,4]thiadiazol-5-yl)methylene-1,3-thiazolidinediones.
    Khazi MI; Belavagi NS; Kim KR; Gong YD; Khazi IA
    Chem Biol Drug Des; 2013 Aug; 82(2):147-55. PubMed ID: 23581650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study.
    Hidalgo-Figueroa S; Estrada-Soto S; Ramírez-Espinosa JJ; Paoli P; Lori G; León-Rivera I; Navarrete-Vázquez G
    Biomed Pharmacother; 2018 Nov; 107():1302-1310. PubMed ID: 30257345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents.
    Sohda T; Mizuno K; Momose Y; Ikeda H; Fujita T; Meguro K
    J Med Chem; 1992 Jul; 35(14):2617-26. PubMed ID: 1635060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and hypoglycemic activity of some new theophylline derivatives.
    Alafeefy AM; Alqasoumi SI; Abdel Hamid SG; El-Tahir KE; Mohamed M; Zain ME; Awaad AS
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):443-8. PubMed ID: 23701264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
    Hidalgo-Figueroa S; Ramírez-Espinosa JJ; Estrada-Soto S; Almanza-Pérez JC; Román-Ramos R; Alarcón-Aguilar FJ; Hernández-Rosado JV; Moreno-Díaz H; Díaz-Coutiño D; Navarrete-Vázquez G
    Chem Biol Drug Des; 2013 Apr; 81(4):474-83. PubMed ID: 23289972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, molecular docking, dynamic simulation and pharmacological characterization of potent multifunctional agent (dual GPR40-PPARγ agonist) for the treatment of experimental type 2 diabetes.
    Hidalgo-Figueroa S; Rodríguez-Luévano A; Almanza-Pérez JC; Giacoman-Martínez A; Ortiz-Andrade R; León-Rivera I; Navarrete-Vázquez G
    Eur J Pharmacol; 2021 Sep; 907():174244. PubMed ID: 34116041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Docking, Synthesis and Biological Evaluation of Sulphonylureas/ Guanidine Derivatives as Promising Antidiabetic Agent.
    Panchal II; Sen DJ; Patel AD; Shah U; Patel M; Navale A; Bhavsar V
    Curr Drug Discov Technol; 2018; 15(4):315-325. PubMed ID: 28969569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, Characterisation, Molecular Docking, Anti-microbial and Anti-diabetic Screening of Substituted 4-indolylphenyl-6-arylpyrimidine-2-imine Derivatives.
    Ramya V; Vembu S; Ariharasivakumar G; Gopalakrishnan M
    Drug Res (Stuttg); 2017 Sep; 67(9):515-526. PubMed ID: 28628926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and biological evaluation of novel sulindac derivatives as partial agonists of PPARγ with potential anti-diabetic efficacy.
    Huang F; Zeng Z; Zhang W; Yan Z; Chen J; Yu L; Yang Q; Li Y; Yu H; Chen J; Wu C; Zhang XK; Su Y; Zhou H
    Eur J Med Chem; 2021 Oct; 222():113542. PubMed ID: 34118723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antihyperglycemic activity of 2-(substituted phenyl)-3-{[4-(1-naphthyl)-1,3-thiazol-2-yl] amino}-4-oxo-1,3-thiazolidin-5-ylacetic acid derivatives.
    Imran M; Yar MS; Khan SA
    Acta Pol Pharm; 2009; 66(1):51-6. PubMed ID: 19226969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, molecular docking, and in vivo antidiabetic evaluation of new benzylidene-2,4-thiazolidinediones as partial PPAR-γ agonists.
    Najmi A; Alam MS; Thangavel N; Taha MME; Meraya AM; Albratty M; Alhazmi HA; Ahsan W; Haque A; Azam F
    Sci Rep; 2023 Nov; 13(1):19869. PubMed ID: 37963936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, in vitro and in silico studies of a PPARγ and GLUT-4 modulator with hypoglycemic effect.
    Navarrete-Vázquez G; Torres-Gómez H; Hidalgo-Figueroa S; Ramírez-Espinosa JJ; Estrada-Soto S; Medina-Franco JL; León-Rivera I; Alarcón-Aguilar FJ; Almanza-Pérez JC
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4575-4579. PubMed ID: 25131539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological activity evaluation of a new class of 2,4-thiazolidinedione compounds as insulin enhancers.
    Huiying Z; Guangying C; Shiyang Z
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):981-989. PubMed ID: 31072232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and Evaluation of the Hypoglycemic and Hypolipidemic Activity of Sulfonamide-benzothiazole Derivatives of Benzylidene-2,4- thiazolidnedione.
    Ahmadi A; Khalili M; Sohrabi L; Delzendeh N; Nahri-Niknafs B; Ansari F
    Mini Rev Med Chem; 2017; 17(8):721-726. PubMed ID: 27903228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: Synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment.
    Bhutani R; Pathak DP; Kapoor G; Husain A; Iqbal MA
    Bioorg Chem; 2019 Mar; 83():6-19. PubMed ID: 30339863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of novel thiazol-2-yl benzamide derivatives as glucokinase activators.
    Charaya N; Pandita D; Grewal AS; Lather V
    Comput Biol Chem; 2018 Apr; 73():221-229. PubMed ID: 29518630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.